x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAA-001076
| Product Information | |
|---|---|
| Product Name | Mouse CCL28 ELISA Kit |
| Species | Mouse |
| Description | Mouse CCL28 ELISA Kit is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of CCL28 protein in cell culture extracts, cell culture supernatant, plasma, serum, and tissue extracts. It uses our proprietary ELISA technology. Quantitate Mouse CCL28 with 4.7 pg/ml sensitivity ELISA technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our ELISA plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. |
| Sample Types | Cell Culture Supernatant, Serum, Plasma, Cell Culture Extracts, Tissue Extracts |
| Detection Range | 62.5 pg/mL - 4000 pg/mL |
| Sensitivity | 4.7 pg/mL |
| Target Information | |
|---|---|
| Target Name | CCL28 |
| UniProt No. | Q9NRJ3 |
| Gene ID | 56477 |
| Target Description | Chemotactic activity for resting CD4, CD8 T-cells and eosinophils. Binds to CCR3 and CCR10 and induces calcium mobilization in a dose-dependent manner. |
| Alternative Names | C C motif chemokine ligand 28; C-C motif chemokine 28; CC chemokine CCL28; CCK 1; CCK1; CCK1 protein; CCL 28; CCL28; CCL28_HUMAN; Chemokine (C-C motif) ligand 28; chemokine (C-C motif) ligand 28 splice variant chi; MEC; Mucosae associated epithelial chemokine; Mucosae-associated epithelial chemokine; Protein CCK1; SCYA28; Small inducible cytokine A28 [Precursor]; small inducible cytokine subfamily A (Cys-Cys), member 28; Small-inducible cytokine A28 |
| Shipping & Storage | |
|---|---|
| Sipping | Shipping on dry ice. |
| Storage | Store at +4°C. Please refer to protocols. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
